Validation study of the association between genetic variant of IL4 and severe radiation pneumonitis in lung cancer patients treated with radiation therapy
Up till now, lung cancer remains as the leading cause of cancer-related mortality worldwide. According to the latest statistical report, there are 2.1 million new lung cancer cases and 1.8 million deaths predicted globally in 2018, nearly close to 1 in 5 (18.4%) of all cancer deaths [1]. China is among the countries with the highest lung cancer rates (above 40 per 100,000). For lung cancer patients, radiotherapy (RT) with or without chemother apy remains to be the fundamental treatment. However, the efficacy of radiotherapy is restrained due to a series of RT-related complications that result in patients’ intolerance.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Yang Tang, Li Yang, Wan Qin, Min'xiao Yi, Bo Liu, Xiang'lin Yuan Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Genetics | Lung Cancer | Radiation Therapy | Radiology | Statistics | Study